Ashwagandha 25:1 High Power – Standardized to 5% Withanolides – Serenity Leaf – Adaptogen for Stress, Calm, Relaxation and Wellness – 120 Vegetable Capsules
13.9€
Price: €14.90 - €13.90
(as of May 17, 2026 01:56:14 UTC – Details)
Product Description
Product Dimensions : 5.8 x 5.8 x 11 cm; 120 g
Manufacturer : Serenity Leaf
ASIN : B0G499JMZC
Country of origin : España
Customer reviews: 4.7 4.7 out of 5 stars (30) var dpAcrHasRegisteredArcLinkClickAction; P.when(‘A’, ‘ready’).execute(function(A) { if (dpAcrHasRegisteredArcLinkClickAction !== true) { dpAcrHasRegisteredArcLinkClickAction = true; A.declarative( ‘acrLink-click-metrics’, ‘click’, { “allowLinkDefault”: true }, function (event) { if (window.ue) { ue.count(“acrLinkClickCount”, (ue.count(“acrLinkClickCount”) || 0) + 1); } } ); } }); P.when(‘A’, ‘cf’).execute(function(A) { A.declarative(‘acrStarsLink-click-metrics’, ‘click’, { “allowLinkDefault” : true }, function(event){ if(window.ue) { ue.count(“acrStarsLinkWithPopoverClickCount”, (ue.count(“acrStarsLinkWithPopoverClickCount”) || 0) + 1); } }); });
High Power 25:1. Our 25:1 concentrated extract is standardized to 5% withanolides and offers a powerful, consistent and stable formula to accompany overall wellness on a daily basis.
➡ Adaptogen for Daily Balance. Ashwagandha is a plant traditionally used to join a balanced lifestyle and accompany the body on a daily basis.
Quiet and harmony every day. Regular use can help promote a sense of calm and harmony, helping to approach daily activities with more serenity.
Well being at the end of the day. Ashwagandha is appreciated by many people to accompany moments of relaxation and promote a feeling of relaxation at the end of the day.
Optimized assimilation. Contains BioPerine, a natural extract known to promote the absorption of ingredients, allowing the body to better take advantage of each intake.
➡ Clean and Vegan Formula. Made from plant-based ingredients, gluten-free and GMO-free. A simple and natural composition, without superfluous additives.
There are no reviews yet.